Recombinant interferon-β blocks proliferation but enhances interleukin-10 secretion by activated human T-cells

Journal of Neuroimmunology

Volumn 67, Issue 2, 1996, Pages 111-118

  Rep, Martin H G ^a,b   Hintzen, Rogier Q ^a,b,c   Polman, Chris H ^d   Van Lier, René A W ^a,b  

^a CENTRAL LABORATORY   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

B cell differentiation; Interleukin 10; Multiple sclerosis; Recombinant interferon (rIFN ); T cell activation

Indexed keywords

CYTOKINE; INTERFERON BETA SERINE; INTERLEUKIN 10; RECOMBINANT BETA INTERFERON;

ADULT; ARTICLE; CHILD; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOREGULATION; LYMPHOCYTE DIFFERENTIATION; MULTIPLE SCLEROSIS; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 0030200026     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-5728(96)00060-4     Document Type: Article

References (48)

1. Abu Khabar, K.S., Armstrong, J.A. and Ho, M. (1992) Type I interferons (IFN-alpha and -beta) suppress cytotoxin (tumor necrosis factor-alpha and lymphotoxin) production by mitogen-stimulated human peripheral blood mononuclear cell. J. Leukoc. Biol. 52, 165-172.
2. Antel, J.P., Bania, M.B., Reder, A. and Cashman, N. (1986) Activated suppressor cell dysfunction in progressive multiple sclerosis. J. Immunol. 137, 137-141.
3. Balkwill, F.R. (1989) Interferons. Lancet 1, 1060-1063.
4. Beck, J., Rondot, P., Catinot, L., Falcoff, E., Kirchner, H. and Wietzerbin, J. (1988) Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations? Acta Neurol. Scand. 78, 318-323.
5. Camenga, D.L., Johnson, K.P., Alter, M. et al. (1986) Systemic recombinant alpha-2 interferon therapy in relapsing multiple sclerosis. Arch. Neurol. 43, 1239-1246.
6. Collart, M.A., Belin, D., Vassalli, J.D., de Kossodo, S. and Vassalli, P. (1986) Gamma interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin I. and urokinase genes, which are controlled by short-lived repressors. J. Exp. Med. 164, 2113-2118.
7. De Jong, R., Stokkers, P., Lamme, E., et al. (1991) Regulation of T-cell differentiation by CD2 and CD28 accessory molecules. Immunology 74, 175-182.
8. Del Prete, G., Maggi, E. and Romagnani, S. (1994) Human Th1 and Th2 cells: functional properties, mechanisms of regulation, and role in disease. Lab. Invest. 70, 299-306.
9. Fiorentino, D.F., Bond, M.W. and Mosmann, T.R. (1989) Two types of mouse T helper cell IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170, 2081-2095.
10. Gillis, S., Ferm, M.M., Ou, W. and Smith, K.A. (1978) T-cell growth factor: parameters of production and a quantitative microassay for activity. J. Immunol. 120. 2027.
11. Hirsch, R.L., Panitch, H.S. and Johnson, K.P. (1985) Lymphocytes from multiple sclerosis patients produce elevated levels of interferon gamma in vitro. J. Clin. Immunol. 5, 386-389.
12. Hirsch, R.L. (1986) Defective autologous mixed lymphocyte reactivity in multiple sclerosis. Clin. Exp. Immunol. 64, 107-113.
13. Hughes, R.A. (1994) Immunotherapy for multiple sclerosis (editorial). J. Neurol. Neurosurg. Psychiatry 57, 3-6.
14. Jacobs, L., Salazar, A.M., Herndon, R., et al. (1986) Multicentre double-blind study of effect of intrathecally administered natural human fibroblast interferon on exacerbations of multiple sclerosis. Lancet 2. 1411-1413.
15. Jacobs, L., Cookfair, D., Rudick, R., et al. (1994) Results of a Phase III Trial of IM Recombinant Beta Interferon as Treatment for MS. J. Neuroimmunol. 54, 1-2, 170.
16. Knobler, R.L., Panitch, H.S., Braheny, S.L., et al. (1984) Clinical trial of natural alpha interferon in multiple sclerosis. Ann. N.Y. Acad. Sci. 436, 382-388.
17. Kuiper, H.M., Jong, R. de, Brouwer, M., Lammers, K., Wijdenes, J. and Van Lier, R.A.W. (1994) Influence of CD28 costimulation on cytokine production is mainly regulated via IL-2. Immunology 83, 38-44.
18. Link, H., (1973) Clin. Chem. Acta 46, 383-389.
19. Massa, P.T., Dorries, R. and ter Meulen, V. (1986) Viral particles induce Ia antigen expression on astrocytes. Nature 320, 543-546.
20. McCarron, R.M., Fallis, R.J. and McFarlin, D.E. (1990) Alterations in T cell antigen specificity and class II restriction during the course of chronic relapsing experimental allergic encephalomyelitis. J. Neuroimmunol. 29, 73-79.
21. Medaer, R., Stinissen, P., Truyen, L., Raus, J. and Zhang, J.W. (1995) Depletion of myelin-basic-protein autoreactive T cells by T-cell vaccination: Pilot trial in multiple sclerosis. Lancet 346, 807-808.
22. Nakagawa, T., Hirano, T., Nakagawa, N., Yoshizaki, K. and Kishimoto, T. (1985) Effect of recombinant IL 2 and gamma-IFN on proliferation and differentiation of human B cells. J. Immunol. 134, 959-966.
23. Nakanishi, K., Malek, T.R., Smith, K.A., Hamaoka, T., Shevach, E.M. and Paul, W.E. (1984) Both interleukin 2 and a second T cell-derived factor in EL-4 supernatant have activity as differentiation factors in IgM synthesis. J. Exp. Med. 160, 1605-1621.
24. Noronha, A., Toscas, A. and Jensen, M.A. (1993) Interferon beta decreases T cell activation and interferon gamma production in multiple sclerosis. J. Neuroimmunol. 46, 145-153.
25. Paty, D.W. and Li, D.K. (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group. Neurology 43, 662-667.
26. Rieckmann, P., Albrecht, M., Kitze, B., et al. (1994) Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis. Neurology 44, 1523-1526.
27. Romagnani, S., (1991) Human TH1 and TH2 subsets: doubt no more. Immunol. Today 12, 256-257.
28. Rose, L.M., Ginsberg, A.H., Rothstein, T.L., Ledbetter, J.A. and Clark, E.A. (1985) Selective loss of a subset of T helper cells in active multiple sclerosis. Proc. Natl. Acad. Sci. USA 82, 7389-7393.
29. Rott, O., Fleischer, B. and Cash, E. (1994) Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur. J. Immunol. 24, 1434-1440.
30. Rudick, R.A., Carpenter, C.S., Cookfair, D.L., Tuohy, V.K. and Ransohoff, R.M. (1993) In vitro and in vivo inhibition of mitogen-driven T-cell activation by recombinant interferon beta. Neurology 43, 2080-2087.
31. Rümke, H., Terpstra, F.G., Huis, B., Out, T.A. and Zeylemaker, W.P. (1982) Immunoglobulin production in human mixed lymphocyte cultures. Implications for cultures of cells from patients and healthy donors. J. Immunol. 128, 696.
32. Salmaggi, A., Dufour, A., Eoli, M., et al. (1994) Study of IL-10 Levels in MS Patients in Different Phases of the Disease. J. Neuroimmunol. 54, 1-2, 193.
33. Selmaj, K., Plater Zyberk, C., Rockett, K.A., et al. (1986) Multiple sclerosis: increased expression of interleukin-2 receptors on lymphocytes. Neurology 36, 1392-1395.
34. Selmaj, K., Raine, C.S., Cannella, B. and Brosnan, C.F. (1991) Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J. Clin. Invest. 87, 949-954.
35. Selmaj, K. and Raine, C.S. (1988) Tumour necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23, 339-346.
36. The IFNB Multiple Sclerosis Study Group (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43, 655-661.
37. Traugott, U. and Lebon, P., (1988) Multiple sclerosis: involvement of interferons in lesion pathogenesis. Ann. Neurol. 24, 243-251.
38. Trinchieri, G. (1994) Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 84 (12), 4008-4027.
39. Van der Meide, P.H., Dubbeld, M. and Schellekens, H. (1985) Monoclonal antibodies to human immune interferon and their use in a sensitive solid-phase ELISA. J. Immunol. Methods 79, 293-305.
40. van der Pouw Kraan, T.C.T.M., Boeije, L.C.M., Troon, J.T.M., Rutschmann, S.K., Wijdenes, J. and Aarden, L.A. (1996) Human IL-13 production is negatively influenced by CD3 engagement. Enhancement of IL-13 production by cyclosporin A. J. Immunol., in press.
41. van der Pouw-Kraan, T., van Cooten, C., Rensink, I. and Aarden, L. (1992) IL-4 production by human T cells. Differential regulation of IL-4 versus IL-2 production. Eur. J. Immunol. 22, 1237-1241.
42. Van Kemenade, F.J., Tellegen, E., Maurice, M.M., et al. (1994) Simultaneous regulation of CD2 adhesion and signaling functions by a novel CD2 monoclonal antibody. J. Immunol. 152, 4425-4432.
43. van Lier, R.A., Brouwer, M., Rebel, V.I., van Noesel, C.J. and Aarden, L.A. (1989) Immobilized anti-CD3 monoclonal antibodies induce accessory cell-independent lymphokine production, proliferation and helper activity in human T lymphocytes. Immunology 68, 45-50.
44. Waldmann, T.A., Goldman, C.K., Robb, R.J., et al. (1984) Expression of interleukin 2 receptors on activated human B cells. J. Exp. Med. 160, 1450-1466.
45. Wong, G.H., Clark Lewis, I., Harris, A.W. and Schrader, J.W. (1984) Effect of cloned interferon-gamma on expression of H-2 and Ia antigens on cell lines of hemopoietic, lymphoid, epithelial, fibroblastic and neuronal origin. Eur. J. Immunol. 14, 52-56.
46. Zhang, J., Weiner, H.L. and Hafler, D.A. (1992) Autoreactive T cells in multiple sclerosis. Int. Rev. Immunol. 9, 183-201.
47. Zubler, R.H., Lowenthal, J.W., Erard, F., Hashimoto, N., Devos, R. and MacDonald, H.R. (1984) Activated B cells express receptors for, and proliferate in response to pure interleukin 2. J. Exp. Med. 160, 1170-1183.
48. Zurawski, G. and De Vries, J.E. (1995) Interleukin-13, an interleukin-4 like cytokine that acts on monocytes and B cells, but not on T cells. Immunol. Today 15, 19-26.